Literature DB >> 16476807

Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

Pablo Castillo1, Bryan Woodruff, Richard Caselli, Steven Vernino, Claudia Lucchinetti, Jerry Swanson, John Noseworthy, Allen Aksamit, Jonathan Carter, Joseph Sirven, Gene Hunder, Vahab Fatourechi, Bahram Mokri, Daniel Drubach, Sean Pittock, Vanda Lennon, Brad Boeve.   

Abstract

BACKGROUND: Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT), often termed Hashimoto encephalopathy, is a poorly understood and often misdiagnosed entity.
OBJECTIVE: To characterize the clinical, laboratory, and radiologic findings in patients with SREAT to potentially improve recognition of this treatable entity.
DESIGN: Retrospective analysis of clinical features and diagnostic test data.
SETTING: Two affiliated tertiary care referral institutions. PATIENTS: Twenty consecutive (6 male) patients diagnosed as having SREAT from 1995 to 2003. MAIN OUTCOME MEASURES: Clinical features and ancillary test findings associated with SREAT.
RESULTS: The median age at disease onset was 56 years (range, 27-84 years). The most frequent clinical features were tremor in 16 (80%), transient aphasia in 16 (80%), myoclonus in 13 (65%), gait ataxia in 13 (65%), seizures in 12 (60%), and sleep abnormalities in 11 (55%). All patients were assigned an alternative misdiagnosis at presentation, most commonly viral encephalitis (n = 5), Creutzfeldt-Jakob disease (n = 3), or a degenerative dementia (n = 4). The most frequent laboratory abnormalities were increased liver enzyme levels in 11, increased serum sensitive thyroid-stimulating hormone levels in 11, and increased erythrocyte sedimentation rate in 5. In only 5 patients (25%) did cerebrospinal fluid abnormalities suggest an inflammatory process. Magnetic resonance imaging abnormalities believed to be related to the encephalopathy were present in 5 patients (26%).
CONCLUSIONS: The clinical, laboratory, and radiologic findings associated with SREAT are more varied than previously reported. Misdiagnosis at presentation is common. This treatable syndrome should be considered even if the serum sensitive thyroid-stimulating hormone level and erythrocyte sedimentation rate are normal, the cerebrospinal fluid profile does not suggest an inflammatory process, and neuroimaging results are normal. Until the pathophysiologic mechanism of this and other autoimmune encephalopathies is better characterized, we believe that descriptive terms that reflect an association rather than causation are most appropriate for this syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476807     DOI: 10.1001/archneur.63.2.197

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  108 in total

1.  Seizures and postictal stupor in a patient with uncontrolled Graves' hyperthyroidism.

Authors:  Nico De Leu; David Unuane; Kris Poppe; Brigitte Velkeniers
Journal:  BMJ Case Rep       Date:  2012-06-01

Review 2.  Neuronal surface antibody-mediated autoimmune encephalitis.

Authors:  Jenny J Linnoila; Myrna R Rosenfeld; Josep Dalmau
Journal:  Semin Neurol       Date:  2014-11-04       Impact factor: 3.420

Review 3.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

4.  Autoimmune encephalopathy.

Authors:  Richard J Caselli; Joseph F Drazkowski; Dean M Wingerchuk
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

5.  Steroid responsive encephalopathy with positive thyroid antibodies. A syndrome, not a diagnosis?

Authors:  Jonathan M Schott; Jason D Warren
Journal:  J Neurol       Date:  2007-03-12       Impact factor: 4.849

Review 6.  Recognizing Autoimmune-Mediated Encephalitis in the Differential Diagnosis of Limbic Disorders.

Authors:  A J da Rocha; R H Nunes; A C M Maia; L L F do Amaral
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-17       Impact factor: 3.825

7.  Steroid-responsive encephalopathy: an under recognised aspect of Hashimoto's thyroiditis.

Authors:  Tanawan Riangwiwat; Jutarat Sangtian; Chutintorn Sriphrapradang
Journal:  BMJ Case Rep       Date:  2015-03-12

Review 8.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 9.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

10.  Hashimoto Encephalopathy as a Complication of Autoimmune Thyroiditis.

Authors:  Alixandria A Fiore; Wilson B Pfeiffer; Syed A A Rizvi; Anais Cortes; Conrad Ziembinski; Ronald Pham; Stephanie Graves; Urvesh Patel
Journal:  Med Princ Pract       Date:  2018-10-24       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.